The Supreme Court Clarifies the Government's FCA Dismissal Power and Invites Constitutional Challenge to the FCA's Qui Tam Provision | Akerman LLP - Health Law Rx

For the second time this month, the United States Supreme Court addressed a circuit split involving the False Claims Act (FCA, 31 U.S.C. §§ 3729 – 3733). Earlier, in the SuperValu...

Related Keywords

United States ,Justice Thoma ,Justice Thomas ,Ucb Inc ,Sequoia Orange Co ,Litigation Branch Fraud Section Michaeld Granston ,Health Law Rx Blog ,Health Res Inc ,United States Court ,United States Supreme Court ,Supervalu Inc ,Baird Neece Packing Corp ,Health Law Rx ,Kaiser Hill Co ,Supervalu ,Bayer Healthcare Pharms Inc ,Supreme Court ,Health Resources Inc ,False Claims Act ,Valu Inc ,Health Resources ,Federal Rule ,Health Res ,Split Among ,First Circuit ,Healthcare Pharms ,Tenth Circuits ,Sequoia Orange ,Seventh Circuit ,Civil Procedure ,Third Circuit ,Slow Bar ,Qui Tam ,Granston Memo ,Litigation Branch ,Fraud Section Michael ,Justices Kavanaugh ,United State ,